Common sense would say that hiring an extra person to oversee a patient’s care would cost a great deal more. However, new research suggests that integrative health care will actually lower cost and improve results in certain cases.

Scientists have increasingly been experimenting with therapies tied to a patient's own stem cells, and peripheral artery disease (PAD) is no exception.

For patients with heart disease, a heart rehabilitation program may do more than better their physical health. Such programs also appear to work by promoting healthy lifestyle decisions.

After certain types of heart attacks, doctors often use stents to prop open the arteries. Another method that may be used involves removing blood clots through thrombus aspiration (TA), but studies have shown mixed long-term results.

Peripheral artery disease (PAD) can be treated by several methods depending on severity of the leg blockage. Bypass surgery in the leg is one option, but less-invasive endovascular surgery is preferred when appropriate.

A team of engineers have taken heart monitoring to the next level with the development of e-bras and vests capable of picking up signs from the heart, which can be sent to doctors and patients via a smart phone.

Looking to improve your heart health whether you are healthy or already suffer from cardiovascular disease? It may be as simple as regular fish consumption, particularly oily varieties such as salmon.

A key to preserving brain function and reducing disability following a stroke is receiving care quickly, however, patients are not receiving timely brain imaging, an important factor in determining the type of stroke and treatment options.

Heart failure patients often take medication to lower their risk of stroke, hemorrhage or dying. A common choice is warfarin (Coumadin), though a large clinical trial has found that cheaper over-the-counter aspirin may be just as effective.

A U.S. Food and Drug Administration panel has voted 7-1 to back Cameron Health's new type of implantable heart defibrillator. It is the first defibrillator that does not require implanting an electrode near the heart.